Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Lobular 1

Interventions

Cisplatin 1041Cyclophosphamide 974Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 760Paclitaxel 740Docetaxel 734Oxaliplatin 706Capecitabine 650Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 327Trastuzumab 324Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 279Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Fluorine-18 × Clear all
NCT04252859 2025-05-18

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

University of Utah

Phase 2 Terminated
44 enrolled 15 charts

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡